Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2006-09-12
2006-09-12
Ponnaluri, Padmashri (Department: 1639)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C435S006120, C435S069100, C435S069700, C435S471000, C435S488000, C435S091500, C435S091500, C435S320100, C530S350000, C536S023100, C536S023400
Reexamination Certificate
active
07105290
ABSTRACT:
The present invention relates to a method for determining whether a compound is capable of binding to a BMP receptor kinase protein complex, the method comprising introducing a sample comprising the compound to the BMP receptor kinase protein complex and allowing the compound to bind to the BMP receptor kinase protein complex, wherein the BMP receptor kinase protein complex is comprised of a BMP type I receptor kinase protein and the BMP receptor kinase protein BRK-3. The invention further relates to a method for determining the concentration of a BMP receptor ligand in a clinical sample, the met-hod comprising introducing the sample comprising the ligand to a BMP receptor kinase protein complex and allowing the ligand to bind to the BMP receptor kinase protein complex, wherein the BMP receptor kinase protein complex is comprised of a BMP type I receptor kinase protein and BMP receptor kinase protein BRK-3. The invention further relates to a host cell co-transfected with an expression vector comprising a DNA sequence that codes for the BMP receptor kinase protein BRK-3 and an expression vector comprising a DNA sequence that codes for a BMP type I receptor kinase protein. The invention further relates to a host cell co-transfected with an expression vector comprising a DNA sequence that codes for a soluble or incomplete BMP type I receptor kinase protein and a soluble or incomplete BMP receptor kinsase protein BRK-3. The invention further relates to a method for determining whether a test compound produces a signal upon binding to a BMP receptor protein complex.
REFERENCES:
patent: 5013649 (1991-05-01), Wang et al.
patent: 5141905 (1992-08-01), Rosen et al.
patent: 5166058 (1992-11-01), Wang et al.
patent: 5168050 (1992-12-01), Hammonds, Jr. et al.
patent: 5216126 (1993-06-01), Cox et al.
patent: 0 369 861 (1990-05-01), None
patent: WO 93/09228 (1990-05-01), None
patent: WO 92/20793 (1992-11-01), None
patent: WO 93/19177 (1993-09-01), None
patent: WO 94/11502 (1994-05-01), None
patent: WO 95/07982 (1995-03-01), None
patent: WO 95/14778 (1995-06-01), None
Attisano, L., J. Cárcamo, F. Ventura, F. M. B. Weis, J. Massagué and J. L. Wrana, “Identification of Human Activin and TGFβ Type I Receptors That Form Heteromeric Kinase Complexes with Type II Receptors”, Cell, vol. 75, pp. 671-680 (Nov. 19, 1993).
Attisano, L., J. L. Wrana, F. López-Casillas and J. Massagué, “TGF-β Receptors and Actions”, Biochemica et Biophysica Acta, vol. 1222, No. 1, pp. 71-80 (May 26, 1994).
Attisano, L., J. L. Wrana, S. Cheifetz and J. Massagué, “Novel Activin Receptors: Distinct Genes and Alternative mRNA Splicing Generate a Repertoire of Serine/Threonine Kinase Receptors”, Cell, vol. 68, pp. 97-108 (Jan. 10, 1992).
Baarends, W. M., M. J. L. van Helmond, M. Post, P. J. C. M. van der Schoot, J. W. Hoogerbrugge, J. P. de Winter, J. T. J. Uilenbroek, B. Karels, L. G. Wilming, J. H. C. Meijers, A. P. N. Themmen and J. A. Grootegoed, “A Novel Member of the Transmembrane Serine/threonine Kinase Receptor Family Is Specifically Expressed in the Gonads and in Mesenchymal Cells Adjacent to the Müllerian Duct”, Development, vol. 120, pp. 189-197 (no month identified 1994).
Basler, K. T. Edlund T. M. Jessell and T. Yamada, “Control of Cell Pattern in the Neural Tube: Regulation of Cell Differentiation bydorsalin-1, a Novel TGFβ Family Member”, Cell, vol. 73, pp. 687-702 (May 1993).
Bassing, C. H., J. M. Yingling, D. J. Howe, T. Wang W. W. He, M. L. Gustafson, P. Shah, P. K. Donahoe and X. F. Wang, “A Transforming Growth Factor β Type I Receptor That Signals to Activate Gene Expression”, Science, vol. 263, pp. 87-89 (Jan. 7, 1994).
Bergonzoni, L. Caccie, P., Cletini, O., Sarmientos, P., & Isacchi, A. (Nov. 15, 1992) “Characterization of a Biologically Active Extracellular Domain of Fibroblast Growth Factor Receptor 1 Express d inEscherichia coli”, Eur. J. Biochem., 210, 823-829.
Blessing, M., L. B. Nanney, L. E. King, C. M. Jones and B. L. Hogan, “Transgenic Mice as a Model to Study the Role of TGF-β-related molecules in Hair Follicles”, Genes Dev., vol. 7, No. 2, pp. 204-215 (Feb. 1993).
Brummel, T.J., V. Twombly, G. Marqués, J.L. Wrana, S.J. Newfeld, L. Attisano, J. Massagué, M.B. O'Connor and W.M. Gelbart, “Characterization and Relationship of dpp Receptors Encoded by theSaxaphoneandThick Veinsgene is Drosphillia”, Cell, vol. 78, pp. 251-261 (Jul. 29, 1994).
Cain, M.J., Garlick, K. & Sweetman, P.M.; “Endothelin-1 Receptor Binding Assay for High Throughput Chemical Screening”, J of Cardiovascular Pharmacology 17, (suppl 7), 150-151.
Cárcamo, J., F. M. B. Weis, F. Ventura, R. Wieser, J. L. Wrana, L. Attisano and J. Massagué, “Type I Receptors Specify Growth-Inhibitory and Transcriptional Responses to Transforming Growth Factor β and Activin”, Molecular and Cellular Biology, vol. 14, No. 6, pp. 3810-3821 (Jun. 1994).
Chen, R-H. and R. Derynck, “Homomeric Interactions Between Type II Transforming Growth Factorβ Receptors”, J. Biol. Chem., vol. 269, No. 36, pp. 22868-22874 (Sep. 9, 1994).
Cunningham, N. S., V. Paralkar and A. H. Reddi, “Osteogenin and Recombinant Bone Morphogenetic Protein 2B Are Chemotactic for Human Monocytes and Stimulate Transforming Growth Factor-β1mRNA Expression”, Proc. Natl. Acad. Sci. USA, vol. 89, pp. 11740-11744 (Dec. 1992).
Drozdoff, V., N. A. Wall and W. J. Pledger, “Expression and Grwoth Inhibitory Effect of Decapentaplegic Vg-related protein 6: Evidence for a Regulatory Role in Keratinocyte Differentiation”, Proc. Natl. Acad. Sci. USA, vol. 91, pp. 5528-5532 (Jun. 1994).
Ebner, R., R.-H. Chen, S. Lawler, T. Zioncheck and R. Derynck, “Determination of Type I Receptor Specificity by the Type II Receptors for TGF-β or Activin”, Science, vol. 262, pp. 900-902 (Nov. 5, 1993).
Estevez, M., L. Attisano, J. L. Wrana, P. S. Albert, J. Massagué and D. L. Riddle, “Thedaf-4Gene Encodes A Bone Morphogenetic Protein Receptor Controlling C.elegansDauer Larva Development”, Nature, vol. 365, pp. 644-649 (Oct. 14, 1993).
Fernandez-Botran, R. (Aug. 1991) “Soluble Cytokine Receptors: Their Role in Immunoregulation”, FASEB J., 5, 2567-2574.
Franzén, P., P. ten Dijke, H. Ichijo, H. Yamashita, P. Schulz, C. H. Heldin and K. Miyazono, Cloning of a TGFβ Type I Receptor That Forms a Heteromeric Complex with the TGFβ Type II Receptor, Cell, vol. 75, pp. 681-692 (Nov. 19, 1993).
Frolik, Charles A.; Wakefield, Lalage M.; Smith, Diane M. & Sporn, Michael B.; “Characterization of a Membrane Receptor for Transforming Growth Factor-β in Normal Rat Kidney Fibroblasts”; J. of Biological Chem.; vol. 259, Sep. 10, 1984, 10995-11000.
Garrison, J.C., “Study of Protein Phosphorylation in Intact Cells”, B: Protein Phosphorylation, A Practical Approach, Hardie, D.G. (ed), Chapter 1, pp. 1-29, (no month identified 1993).
Georgi, L. L., P. S. Albert and D. L. Riddle, “daf-1, a C. elegans Gene Controlling Dauer Larva Development, Encodes a Novel Receptor Protein Kinase”, Cell, vol. 61, pp. 635-645 (May 18, 1990).
Graff, Jonathan M.; Thies, R. Scott; Song, Jeffrey J.; Celeste, Anthony J. & Melton, Douglas A.; “Studies with a Xenopus BMP Receptor Suggest That Ventral Mesoderm-Inducing Signals Override Dorsal Signals In Vivo”, Cell, vol. 79, Oct. 7, 1994; 169-179.
Hanks, Steven K.; Quinn, Anne Marie & Hunter, Tony; “The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains”; Science, vol. 241, 42-52.
Hardie, D. Grahame, “Protien Phosphorylation a Practical Approach”, IRL Press at Oxford University Press, Published 1993.
He, W. W., M. L. Gustafson, S. Hirobe and P. K. Donahoe, “Developmental Expression of Four Novel Serine
Corstanje Brahm J.
McDow-Dunham Kelly L.
Ponnaluri Padmashri
The Procter & Gamble & Company
LandOfFree
Use of a BMP protein receptor complex for screening bone... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a BMP protein receptor complex for screening bone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a BMP protein receptor complex for screening bone... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3617540